Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection Manuel Mendizabal; Ezequiel Ridruejo; Federico Piñero; Margarita Anders; Martín Padilla; Luis G. Toro; Aldo Torre; Pedro Montes; Alvaro Urzúa; Esteban Gonzalez Ballerga; María Dolores Silveyra; Douglas Michelato; Javier Díaz; Mirta Peralta; Josefina Pages; Sandro Ruiz García; Isabel Gutierrez Lozano; Yuridia Macias; Daniel Cocozzella; Norberto Chavez-Tapia; Martín Tagle; Alejandra Dominguez; Adriana Varón; Emilia Vera Pozo; Fátima Higuera-de la Tijera; Carla Bustios; Damián Conte; Nataly Escajadillo; Andrés J Gómez; Laura Tenorio; Mauricio Castillo Barradas; Maria Isabel Schinoni; Fernando Bessone; Fernando Contreras; Leyla Nazal; Abel Sanchez; Matías García; Julia Brutti; María Cecilia Cabrera; Godolfino Miranda-Zazueta; German Rojas; Maximo Cattaneo; Graciela Castro-Narro; Fernando Rubinstein; Marcelo O. Silva;

P-6 PREVALENCE AND CLINICAL CHARACTERISTICS OF LEAN NON-ALCOHOLIC FATTY LIVER DISEASE IN MÉXICO Erick Augusto Jasso; Jesús Alejandro Ruiz; Antonio Olivas; Luis Carlos Chávez; Juan Adrian Torres; Alfonso Fernández; Abraham Ramos; Josealberto Sebastiano Arenas; Graciela Castro; Aldo Torre;

Prolonged-release pirfenidone in patients with compensated cirrhosis. Final results of the multicenter study ODISEA, controlled against placebo, plus standardized care_2023 Linda E. Munoz-Espinosa; Aldo Torre; Laura Cisneros; Iaarah Montalvo-Gordon; René Malé-Velázquez; Scherezada Mejía; Juan Ramón Aguilar-Ramírez; Javier Lizardi-Cervera; María E. Icaza-Chávez; Frida Gasca-Díaz; Larissa Hernández-Hernández; Paula Cordero-Perez; Luis A. Chi-Cervera; Lilian Torres-Made; Fátima Rodríguez-Álvarez; Graciela Tapia; Jorge Luis Poo;